Marshall Wace’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Sell |
135,841
-76,343
| -36% | -$155K | ﹤0.01% | 2214 |
|
|
2025
Q1 | $397K | Buy |
212,184
+145,866
| +220% | +$273K | ﹤0.01% | 2053 |
|
|
2024
Q4 | $179K | Sell |
66,318
-33,056
| -33% | -$89.3K | ﹤0.01% | 2208 |
|
|
2024
Q3 | $376K | Buy |
+99,374
| New | +$376K | ﹤0.01% | 1891 |
|
|
2022
Q1 | – | Sell |
-8,855
| Closed | -$44K | – | 2537 |
|
|
2021
Q4 | $44K | Sell |
8,855
-49,523
| -85% | -$246K | ﹤0.01% | 2876 |
|
|
2021
Q3 | $391K | Sell |
58,378
-12,685
| -18% | -$85K | ﹤0.01% | 1959 |
|
|
2021
Q2 | $563K | Buy |
+71,063
| New | +$563K | ﹤0.01% | 1626 |
|
|
2020
Q3 | – | Sell |
-26,770
| Closed | -$181K | – | 1496 |
|
|
2020
Q2 | $181K | Sell |
26,770
-47,470
| -64% | -$321K | ﹤0.01% | 1394 |
|
|
2020
Q1 | $513K | Sell |
74,240
-62,072
| -46% | -$429K | 0.01% | 960 |
|
|
2019
Q4 | $1.16M | Buy |
136,312
+97,217
| +249% | +$828K | 0.01% | 908 |
|
|
2019
Q3 | $193K | Buy |
39,095
+19,210
| +97% | +$94.8K | ﹤0.01% | 1244 |
|
|
2019
Q2 | $110K | Sell |
19,885
-8,462
| -30% | -$46.8K | ﹤0.01% | 1234 |
|
|
2019
Q1 | $143K | Sell |
28,347
-707,555
| -96% | -$3.57M | ﹤0.01% | 1373 |
|
|
2018
Q4 | $6.95M | Buy |
735,902
+722,511
| +5,395% | +$6.83M | 0.07% | 346 |
|
|
2018
Q3 | $107K | Buy |
+13,391
| New | +$107K | ﹤0.01% | 1096 |
|